Eleven Amino Acid Glucagon-like Peptide-1 Receptor Agonists with Antidiabetic Activity
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide 1 (GLP-1) is a 30 or 31 amino acid peptide hormone that contributes to the physiological regulation of glucose homeostasis and food intake. Herein, we report the discovery of a novel class of 11 amino acid GLP-1 receptor agonists. These peptides consist of a structurally optimized 9-mer, which is closely related to the N-terminal 9 amino acids of GLP-1, linked to a substituted C-terminal biphenylalanine (BIP) dipeptide. SAR studies resulted in 11-mer GLP-1R agonists with similar in vitro potency to the native 30-mer. Peptides 21 and 22 acutely reduced plasma glucose excursions and increased plasma insulin concentrations in a mouse model of diabetes. These peptides also showed sustained exposures over several hours in mouse and dog models. The described 11-mer GLP-1 receptor agonists represent a new tool in further understanding GLP-1 receptor pharmacology that may lead to novel antidiabetic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Buse, J. B., Henry, R. R., Han, J., Kim, D. D., Fineman, M. S., Baron, A. D., & for the Exenatide-113 Clinical Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2628 · Cited by 1,346
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000
Nauck, M. A., Heimesaat, M. M., Behle, K., Holst, J. J., Nauck, M. S., Ritzel, R., Hüfner, M., & Schmiegel, W. H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8355 · Cited by 605
Agersø, H., Jensen, L. B., Elbrønd, B., Rolan, P., & Zdravkovic, M. (2002) · Diabetologia · doi:10.1007/s00125-001-0719-z · Cited by 510
Vilsbøll, T., Agersø, H., Krarup, T., & Holst, J. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021053 · Cited by 444
Elbrønd, B., Jakobsen, G., Larsen, S., Agersø, H., Jensen, L. B., Rolan, P., Sturis, J., Hatorp, V., & Zdravkovic, M. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1398 · Cited by 279
Madsen, K., Knudsen, L. B., Agersoe, H., Nielsen, P. F., Thøgersen, H., Wilken, M., & Johansen, N. L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070861j · Cited by 244
Small-molecule agonists for the glucagon-like peptide 1 receptor
Knudsen, L. B., Kiel, D., Teng, M., Behrens, C., Bhumralkar, D., Kodra, J. T., Holst, J. J., Jeppesen, C. B., Johnson, M. D., de Jong, J. C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605701104 · Cited by 232
Glucagon-like peptide-1: From extract to agent. The Claude Bernard Lecture, 2005
Holst, J. J. (2006) · Diabetologia · doi:10.1007/s00125-005-0107-1 · Cited by 228
Research works printed but not linked: 27
- Wild S., 2004, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047 · DOI · Paper page
- Holst J. J., 1987, FEBS Lett., 211, 169, 10.1016/0014-5793(87)81430-8 · DOI · Paper page
- Kreymann B., 1987, Lancet, 2, 1300, 10.1016/S0140-6736(87)91194-9 · DOI · Paper page
- Mojsov S., 1987, J. Clin. Invest., 79, 616, 10.1172/JCI112855 · DOI · Paper page
- Nauck M. A., 1997, Am. J. Physiol., 273, E981
- Davis H. R., 1998, Obes. Res., 6, 147, 10.1002/j.1550-8528.1998.tb00329.x · DOI · Paper page
- Drucker D. J., 2003, Mol. Endocrinol., 17, 161, 10.1210/me.2002-0306 · DOI · Paper page
- Larsen J., 2001, Diabetes Care, 24, 1416, 10.2337/diacare.24.8.1416 · DOI · Paper page
- Mentlein R., 1999, Regul. Pept., 85, 9, 10.1016/S0167-0115(99)00089-0 · DOI · Paper page
- Green B. D., 2007, Best Pract. Res., Clin. Endocrinol. Metab., 21, 497, 10.1016/j.beem.2007.09.003 · DOI
- Chen D., 2007, Proc. Natl. Acad. Sci. U.S.A., 104, 943, 10.1073/pnas.0610173104 · DOI · Paper page
- Rink H., 1987, Tetrahedron Lett., 28, 3787, 10.1016/S0040-4039(00)96384-6 · DOI · Paper page
- King D. S., 1990, Int. J. Pept. Protein Res., 36, 255, 10.1111/j.1399-3011.1990.tb00976.x · DOI · Paper page
- Gefel D., 1990, Endocrinology, 126, 2164, 10.1210/endo-126-4-2164 · DOI · Paper page
- Suzuki S., 1989, Endocrinology, 125, 3109, 10.1210/endo-125-6-3109 · DOI
- Adelhorst K., 1994, J. Biol. Chem., 269, 6275, 10.1016/S0021-9258(17)37366-0 · DOI · Paper page
- Gallwitz B., 1994, Eur. J. Biochem., 225, 1151, 10.1111/j.1432-1033.1994.1151b.x · DOI
- Siegel E. G., 1999, Regul. Pept., 79, 93, 10.1016/S0167-0115(98)00155-4 · DOI
- Deacon C. F., 1998, Diabetologia, 41, 271, 10.1007/s001250050903 · DOI · Paper page
- Ritzel U., 1998, J. Endocrinol., 159, 93, 10.1677/joe.0.1590093 · DOI
- Knudsen L. B., 2000, J. Med. Chem., 43, 1664, 10.1021/jm9909645 · DOI · Paper page
- Parker J. C., 1998, J. Pept. Res., 52, 398, 10.1111/j.1399-3011.1998.tb00664.x · DOI
- Raufman J. P., 1992, J. Biol. Chem., 267, 21432, 10.1016/S0021-9258(19)36628-1 · DOI · Paper page
- Thornton K., 1994, Biochemistry, 33, 3532, 10.1021/bi00178a009 · DOI
- Murage E. N., 2008, Bioorg. Med. Chem., 16, 10106, 10.1016/j.bmc.2008.10.006 · DOI
- Fineman M. S., 2004, Diabetes Metab. Res. Rev., 20, 411, 10.1002/dmrr.499 · DOI · Paper page
- Ritzel R., 1995, Diabetologia, 38, 720, 10.1007/BF00401846 · DOI · Paper page
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“54,55 By doing so, the resulting product has a higher similarity or homology to the amino acid sequence of human GLP-1.”
BackgroundGraaf, C. D., Donnelly, D., Wootten, D., Lau, J., Sexton, P. M., Miller, L. J., Ahn, J.-M., Liao, J., Fletcher, M. M., Yang, D., et al. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011395 · Cited by 403
The structure and function of the glucagon‐like peptide‐1 receptor and its ligands
Donnelly, D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01687.x · Cited by 292
Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics
Ding, Y., Ting, J. P., Liu, J., Al-Azzam, S., Pandya, P., & Afshar, S. (2020) · Amino Acids · doi:10.1007/s00726-020-02890-9 · Cited by 200
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor
Griffith, D. A., Edmonds, D. J., Fortin, J.-P., Kalgutkar, A. S., Kuzmiski, J. B., Loria, P. M., Saxena, A. R., Bagley, S. W., Buckeridge, C., Curto, J. M., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01856 · Cited by 192
Self-citation
Metadata
- Authors
- Mapelli, C., Natarajan, S. I., Meyer, J.-P., Bastos, M. M., Bernatowicz, M. S., Lee, V. G., Pluscec, J., Riexinger, D. J., Sieber-McMaster, E. S., Constantine, K. L., Smith-Monroy, C. A., Golla, R., Ma, Z., Longhi, D. A., Shi, D., Xin, L., Taylor, J. R., Koplowitz, B., Chi, C. L., Khanna, A., Robinson, G. W., Seethala, R., Antal-Zimanyi, I. A., Stoffel, R. H., Han, S., Whaley, J. M., Huang, C. S., Krupinski, J., & Ewing, W. R.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-08-24
- Volume
- 52
- Issue
- 23
- Pages
- 7788-7799
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2081293118
- Cited by
- 74
- References
- 11
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.